Objectives
The main aim of this study was to investigate the prevalence and molecular characteristics of the
mcr-1
gene in
Escherichia coli
isolates obtained from all patients with bloodstream infections over a year in a Chinese teaching hospital. We also assessed the susceptibility profiles of the
mcr-1
-positive strains and prognostic impact of this gene on the patients.
Methods
A total of 144 consecutive, non-repetitive
E. coli
isolates causing bloodstream infections were collected at a teaching hospital in Changsha, China from January to December 2016. The presence of the
mcr-1
gene was assessed by PCR. All
mcr-1
-positive
E coli
isolates were characterized by antimicrobial susceptibility testing, multilocus sequence typing (MLST), a conjugation experiment, and plasmid replicon typing. Clinical data were obtained from medical records.
Results
The
mcr-1
gene was detected in three (2.1%) of the 144
E. coli
isolates. The three
mcr-1
-positive
E. coli
isolates were resistant to colistin. All three isolates showed a lower resistance to other classes of antibacterials, with all three being susceptible to carbapenems. The MLST results indicated that the three
E. coli
isolates were assigned to three different sequence types: ST457, ST101, and ST1413, respectively. The conjugation experiment showed that the
mcr-1
gene was successfully transferred to the recipient (
E. coli
EC600) from two isolates, one of which possessed IncI1 replicons and the other of which carried IncHI2 and IncN replicons. The patients with bloodstream infections caused by
mcr-1
-positive isolates had severe underlying diseases and were cured after antibacterial treatment.
Conclusion
The prevalence of the
mcr-1
gene in patients with
E. coli
bloodstream infection was 2.1% in Changsha, China. The
mcr-1
-positive
E. coli
isolates had varied susceptibility profiles, although all three were susceptible to carbapenems. This therapeutic window is crucial given the risk of rapid deterioration in high-incidence areas worldwide.